Skip to main content
Clinical Trials/NCT05597137
NCT05597137CompletedNot Applicable

To Explore the Regulatory Effect of Zinc on Intestinal Flora in Healthy Adults # A Single-center, Prospective, Self-controlled Trial

The Seventh Affiliated Hospital, Southern Medical University1 site in 1 country56 target enrollmentStarted: March 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
56
Locations
1
Primary Endpoint
metabolomic analysis of serum and feces

Study Overview

Brief Summary

In this A Single-center, Prospective, Self-controlled trial, subjects should avoid a high-Zinc diet for 2 weeks and then take Zinc supplements for 2 weeks.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
20 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy adults aged 20-30 years from the general community were recruited to participate in the study voluntarily without underlying diseases.

Exclusion Criteria

  • Patients who have taken antibiotics orally in the past 3 months or have acute or chronic inflammation; Those who have taken hormones within 3 months; Have taken any drugs that may interfere with glucose and lipid metabolism (such as insulin, glyburide, indomethacin, phentolamine, fuuside, phenytoin sodium, cortisone, etc.) and have had probiotic intervention within 1 month; smokers and drinkers; Uncontrollable mental disorders (including hospitalization history of mental illness); (6) Currently attending a weight loss or weight management course; prescribed diet for specific or other reasons (e.g. celiac disease); pregnant or lactating women; Patients with cardiac and renal insufficiency; Patients with other underlying diseases; Long-term constipation.

Outcomes

Primary Outcomes

metabolomic analysis of serum and feces

Time Frame: 14days,28 days

To determine the alteration of gut microbiota after Zn supplementary.

The blood levels of Zn2+ in each study phase

Time Frame: 14days,28 days

The blood levels of Zn2+ would be detected on day 14 and day 28.

Number of participantswith abnormal laboratory tests results

Time Frame: 14days,28 days

If there are abnormal situations during the experiment that may pose significant risks to the health or safety of the participants, the research team may need to terminate the experiment to ensure participant safety. Only

The fecal Zn2+ concentration in each study phase

Time Frame: 14days,28 days

The fecal Zn2+ concentration would be detected on day 14 and day 28.

16S rDNA sequencing

Time Frame: 14days,28 days

16S rDNA sequencing technology was used to identify the structural and functional changes of intestinal microbiota before and after Zinc supplementation.

Secondary Outcomes

  • Direct bilirubin concentration after 14days oral Zn.(14days,28 days)
  • Total bilirubin concentration after 14days oral Zn.(14days,28 days)
  • Indirect bilirubin concentration after 14days oral Zn.(14days,28 days)
  • uric acid concentration after 14days oral Zn.(14days,28 days)
  • total triglyceride concentration after 14days oral Zn.(14days,28 days)
  • total protein concentration after 14days oral Zn.(14days,28 days)
  • aspartate transaminase concentration after 14days oral Zn.(14days,28 days)
  • alanine transaminase concentration after 14days oral Zn.(14days,28 days)
  • albumin concentration after 14days oral Zn.(14days,28 days)
  • total cholesterol concentration after 14days oral Zn.(14days,28 days)
  • Urea concentration after 14days oral Zn.(14days,28 days)
  • HDL-C concentration after 14days oral Zn.(14days,28 days)
  • LDL-C concentration after 14days oral Zn.(14days,28 days)
  • Red blood cells analysis after 14days oral Zn.(14days,28 days)
  • Plateltes analysis after 14days oral Zn.(14days,28 days)
  • Neutrophil cells analysis after 14days oral Zn.(14days,28 days)
  • Eosinophil cells analysis after 14days oral Zn.(14days,28 days)
  • Basophil cells analysis after 14days oral Zn.(14days,28 days)
  • Lymphocyte cells analysis after 14days oral Zn.(14days,28 days)
  • Monocyte cells analysis after 14days oral Zn.(14days,28 days)
  • White blood cells analysis after 14days oral Zn.(14days,28 days)

Investigators

Sponsor
The Seventh Affiliated Hospital, Southern Medical University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yu Chen

chief physician

The Seventh Affiliated Hospital, Southern Medical University

Study Sites (1)

Loading locations...

Similar Trials